Get the Stockscreener App
0.0173
16.46%
-0.0034
After Hours:
.02
0.00275
+15.93%
Nls Pharmaceutics Ag stock is traded at $0.0173, with a volume of 1,300.
It is down -16.46% in the last 24 hours and up +23.23% over the past month.
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.
See More
Previous Close:
$0.0207
Open:
$0.01782
24h Volume:
1,300
Relative Volume:
0.05
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-27.82%
1M Performance:
+23.23%
6M Performance:
+275.04%
1Y Performance:
+18.98%
1-Day Range:
$0.0173
$0.0178
1-Week Range:
$0.0156
$0.0324
52-Week Range:
$0.0009
$0.0698
Nls Pharmaceutics Ag Stock (NLSPW) Company Profile
Name
Nls Pharmaceutics Ag
Sector
Industry
Phone
41 44 512 21 50
Address
The Circle 6, Zurich
Compare NLSPW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NLSPW
Nls Pharmaceutics Ag
|
0.0173 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.44 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.90 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.74 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
814.17 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
313.54 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nls Pharmaceutics Ag Stock (NLSPW) Latest News
What earnings revisions data tells us about NLS Pharmaceutics AG Equity WarrantJuly 2025 Market Mood & Target Return Focused Picks - newser.com
What’s the recovery path for long term holders of NLS Pharmaceutics AGJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Will NLS Pharmaceutics AG Equity Warrant bounce back from current supportWeekly Profit Report & Community Verified Trade Signals - newser.com
Does NLS Pharmaceutics AG Equity Warrant show high probability of reboundWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
Published on: 2025-10-21 21:37:23 - newser.com
What does recent volatility data suggest for NLS Pharmaceutics AGEarnings Recap Summary & Growth Focused Investment Plans - newser.com
How to build a dashboard for NLS Pharmaceutics AG Equity Warrant stockDip Buying & Risk Controlled Stock Alerts - newser.com
Will NLS Pharmaceutics AG Equity Warrant stock go up soonMarket Activity Report & Real-Time Chart Breakout Alerts - newser.com
How to integrate NLS Pharmaceutics AG Equity Warrant into portfolio analysis tools2025 Price Momentum & Breakout Confirmation Alerts - newser.com
Applying big data sentiment scoring on NLS Pharmaceutics AG Equity WarrantJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Quantitative breakdown of NLS Pharmaceutics AG Equity Warrant recent moveOil Prices & Smart Swing Trading Alerts - newser.com
Published on: 2025-10-21 18:00:44 - newser.com
Real time alert setup for NLS Pharmaceutics AG performanceQuarterly Trade Summary & Free Verified High Yield Trade Plans - newser.com
Custom watchlist performance reports with NLS Pharmaceutics AG Equity Warrant2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Will NLS Pharmaceutics AG Equity Warrant stock gain from lower inflationMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com
NLS Pharmaceutics AG Equity Warrant stock chart pattern explainedJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com
Sentiment analysis tools applied to NLS Pharmaceutics AG Equity WarrantJuly 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
NLS Pharmaceutics AG stock trend outlook and recovery pathJuly 2025 Patterns & Daily Profit Maximizing Tips - newser.com
Is NLS Pharmaceutics AG Equity Warrant stock reversal real or fakeJuly 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com
Evaluating NLS Pharmaceutics AG with trendline analysisMarket Trend Review & Expert-Curated Trade Recommendations - newser.com
Combining machine learning predictions for NLS Pharmaceutics AGEarnings Miss & Low Risk High Reward Ideas - newser.com
Is NLS Pharmaceutics AG a candidate for recovery playEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com
Is NLS Pharmaceutics AG stock positioned well for digital economyPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com
How to track smart money flows in NLS Pharmaceutics AGJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Will NLS Pharmaceutics AG stock split attract more investorsTrade Risk Report & Weekly Top Gainers Trade List - newser.com
Applying Elliott Wave Theory to NLS Pharmaceutics AGQuarterly Portfolio Report & Expert Approved Momentum Trade Ideas - newser.com
Real time pattern detection on NLS Pharmaceutics AG Equity Warrant stock2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
What’s next for NLS Pharmaceutics AG Equity Warrant stock priceJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Will NLS Pharmaceutics AG Equity Warrant stock outperform value stocksQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Regression analysis insights on NLS Pharmaceutics AG Equity Warrant performanceQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com
Nls Pharmaceutics Ag Stock (NLSPW) Financials Data
There is no financial data for Nls Pharmaceutics Ag (NLSPW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.71%
0.87%
Cap:
|
Volume (24h):